Questions people actually ask.
Real questions from Reddit, ASEANNOW, and the Panya quiz. Honest answers with the sources that back them. Updated as the market changes.
Reordered for the US. Same answers for everyone, your region on top.
Same active ingredient. Different manufacturer, formulation, and regulatory status. For most US patients on a quality 503A pharmacy, the clinical difference is small. For an unknow...
Compounded semaglutide from a PCAB-accredited 503A pharmacy with USP-71 sterility testing is clinically similar to brand Wegovy. The variable is the pharmacy, not the molecule. The...
Both are tirzepatide made by Eli Lilly. Same molecule, same supply chain, same factory. Mounjaro is the brand for type-2 diabetes; Zepbound is the brand for chronic weight manageme...
Average in the SURMOUNT-1 trial was 15 percent at 5 mg, 19.5 percent at 10 mg, and 20.9 percent at 15 mg over 72 weeks. The real-world range is wider because 45 percent of trial us...
Most side effects are GI and manageable with slow dose titration. The ones that matter clinically: pancreatitis (rare but serious), medullary thyroid carcinoma risk if personal or ...
In most countries, no. The exception is research-chem direct vendors operating under the 'research use only' legal fiction, which is legal to buy in some jurisdictions for personal...
SURMOUNT-4 (NEJM 2024) showed an average 14 percentage points of weight regain within 12 months of stopping. Hunger and food noise return within 4 to 6 weeks. The realistic options...
For most weight-loss patients, Mounjaro (tirzepatide) is the better first choice if you can get it: higher average loss, similar tolerability. Wegovy (semaglutide) wins on three sp...
GLP-1 pens travel fine with a few precautions. Carry-on only, original packaging with the prescription, insulated pouch or ice pack for trips over 8 hours. Most countries permit pe...
If you have a specific tendon or joint injury that has plateaued on conservative management and you accept that the human evidence is thin, then yes, on a defined 4 to 6 week cycle...
BPC-157 if your injury is tendon, ligament, or gut. TB-500 if it's soft tissue (muscle tear, joint capsule). Stacking both is the community default but the human evidence does not ...
If you want appetite + a small lean-mass gain on a calorie surplus and you accept the prolactin and insulin-resistance side effects, then yes for a 12 to 16 week run. For pure reco...
Topical GHK-Cu at 2 to 3 percent has real human-trial evidence for fine-line reduction, photoaging recovery, and hair follicle stimulation. Injectable GHK-Cu for systemic anti-agin...
For documented clinical NAD+ deficiency or specific neurodegenerative protocols, possibly yes under medical supervision. For general longevity / anti-aging in healthy adults, the h...
Documented adult GH deficiency: yes under medical supervision. Sleep + body comp + recovery in healthy adults: ipamorelin + CJC-1295 (no DAC) nightly at 250-300 mcg has community s...
Short-term tolerability looks decent in user reports. Long-term: unknown, with one real mechanism-level concern. Dihexa amplifies HGF signaling at the c-MET receptor; that pathway ...
If you have any dysplastic nevi or family history of melanoma: no. For everyone else: documented short-term tanning works, libido and appetite effects are real, and the case-report...
Different mechanism, different feel. Tesofensine is a triple monoamine reuptake inhibitor with Astrup 2008 Phase 3 data of ~11% weight loss at 1 mg over 24 weeks. Feels closer to a...
If tirzepatide is working, stay. If plateaued and curious, wait for retatrutide's Phase 3 readouts (TRIUMPH-1, 2026-2027) before chasing research-chem. Phase 2 showed 24.2% weight ...
On the 2024 REDEFINE-1 readout: no, not meaningfully better. CagriSema produced 22.7% mean weight loss at 68 weeks, similar to tirzepatide's SURMOUNT-1 (22.5% at 72 weeks). The pre...
Mechanism plausibly works for men because PT-141's effect is central (brainstem arousal pathways), not peripheral (penile blood flow). Off-label community use is widespread with po...
Bench science is real and novel. MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, identified by Lee 2015 (Cell Metab). Animal data shows insulin sensitivity + exerci...
Russian-trial-validated for stroke recovery (approved as a medicine there). Nootropic / focus claims are extrapolation, supported by Russian clinical use but thinner Western eviden...
For sarcoidosis-associated small-fiber neuropathy: yes, real Phase 2 data (Heij 2012, Dahan 2013) showed symptom + corneal-nerve-fiber-density improvement at 4 mg / 28 days. For di...
Probably not. Sumithran 2008 Phase 2b in 537 obese adults at four doses failed to differentiate from placebo over 24 weeks. The compound is still sold as a fat-loss peptide but the...
Standard community recovery stack: 250 mcg BPC-157 sub-q daily plus 2 mg TB-500 sub-q twice weekly for 4 to 6 weeks loading, then BPC-157 at 3 to 4 times weekly plus TB-500 once we...
CagriSema is Novo Nordisk's combination of cagrilintide (amylin agonist) plus semaglutide (GLP-1 agonist). Phase 3 REDEFINE-1 readout 2024 showed about 22.7 percent mean weight los...
Most tirzepatide nausea resolves within 2 to 3 weeks at a stable dose. Hold the current dose rather than escalating, eat smaller meals, prioritize protein, avoid high-fat meals, hy...
Refrigerated 2 to 8 C is the manufacturer storage spec. Once in use, most pens tolerate room temperature up to 30 C for 21 to 30 days depending on the brand. Heat above 30 C, freez...
Bangkok clinic prices for brand Mounjaro run 6,500 to 16,500 THB per month (about $180 to $450 USD) for a 5 to 10 mg weekly protocol, consultation included. Direct research-chem ve...
Three legitimate channels in Thailand: licensed private clinics (brand Mounjaro, doctor-prescribed), vetted direct vendors (research-grade tirzepatide, COA-backed), and expat teleh...
UK private telehealth runs roughly £150 to £250 per month for brand Mounjaro at the 5 to 10 mg target dose, consultation included. Boots Online Doctor and Asda Online Doctor sit at...
Wegovy has been on the TGA medicine shortages list since launch and supply is intermittent across all dose strengths in April 2026. Novo Nordisk Australia has flagged the constrain...
Voy is a CQC-registered UK telehealth operator running since 2023 with GPhC-registered dispensing pharmacies. Panya scored Voy 74 of 100 against the 11-signal rubric. Regulatory si...
Thailand at 6,500 to 16,500 THB per month ($180 to $450 USD) is the cheapest legitimate Mounjaro market in Southeast Asia. Vietnam and Bali run cheaper for compounded semaglutide v...
Singapore private clinics run SGD 550 to 900 per month for brand Mounjaro at the 5 to 10 mg target dose, plus SGD 80 to 200 for the consultation. HSA-registered for T2D and weight ...
Three legitimate Bali channels: international hospitals (BIMC, Siloam Denpasar, Kasih Ibu) for brand Wegovy or compounded semaglutide, expat-facing telehealth, and direct prescript...
FV Hospital, Vinmec, Family Medical Practice, and Raffles Medical Vietnam are the four expat-facing channels. Compounded semaglutide runs VND 4,000,000 to 7,500,000 per month ($160...
Yes for personal use with a doctor's letter and original packaging. UAE MOH classifies GLP-1s as prescription-only. Up to 3 months supply is generally tolerated at customs with Eng...
Not here? Ask through the quiz.
The questions above are the common cases. The answer for your specific profile, region, budget, and urgency comes from our 2-minute quiz. One email. No list.